Clinical studies have shown that decreased ChAT activity, combined with Aβ-induced interference in neurotransmitter synthesis, release, and metabolism, leads to reduced ACh levels, a key mechanism underlying cognitive impairment (Zhang, J. et al., 2024). Here, CHAT is linked to Cognitive impairment.